The World Health Organization (WHO) has released its first-ever comprehensive global guidelines addressing child and adolescent obesity, establishing a clear…
Read More
FDA issues final PDUFA meeting guidance, expands use of written responses
The U.S. Food and Drug Administration (FDA) has officially finalized its long-awaited guidance regarding formal meetings between the agency and…
Read More
FDA issues final PDUFA meeting guidance, expands use of written responses
The U.S. Food and Drug Administration (FDA) has officially finalized its long-awaited guidance regarding formal meetings between the agency and…
Read More
FDA issues final PDUFA meeting guidance, expands use of written responses
The U.S. Food and Drug Administration (FDA) has officially finalized its long-anticipated guidance regarding formal meetings between the agency and…
Read More
FDA Issues Landmark Guidance to Enhance Pregnancy Safety Data for Medications
The US Food and Drug Administration (FDA) has unveiled its comprehensive final guidance for industry on collecting crucial post-marketing safety…
Read More
FDA Issues Complete Response Letter to Replimune’s RP1 for Advanced Melanoma
The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding Replimune Group’s Biologics License Application…
Read More
